Wells Fargo’s bluebird bio BLUE Stock Holding History

Wells Fargo’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-180	Closed	-$11.4K	–	7590
2023 Q1	$11.4K	Buy	+180	New	+$20.6K	﹤0.01%	5815
2021 Q2	–	Sell	-1,382	Closed	-$540K	–	6910
2021 Q1	$540K	Buy	+1,382	New	+$681K	﹤0.01%	4641

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's BLUE Position: Q2 2025 in Review

Wells Fargo sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 6,499 shares — an estimated $31.7K sold.

Wells Fargo first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $44.3M in Q1 2015. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Wells Fargo reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Wells Fargo sold 6,499 bluebird bio shares in Q2 2025, an estimated $31.7K.
Wells Fargo first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
Wells Fargo's bluebird bio position peaked at $44.3M in Q1 2015.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.